CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,032,885
- in 7 filings, $3.7M under 10b5-1 plans
Net −$4,032,885. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −2,085 | $73.84 | $154K | 154,931 |
| 2025-03-03 | Wassil Jim CHIEF OPERATING OFFICER | Shares withheld for taxes 10b5-1 | −3,015 | $72.10 | $217K | 151,916 |
| 2025-03-03 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −2,638 | 0 | ||
| 2025-03-03 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −5,362 | 71,664 | ||
| 2025-03-03 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −7,984 | $72.10 | $576K | 498,242 |
| 2025-02-28 | GUGGENHIME ANDREW PRESIDENT AND CFO | Shares withheld for taxes | −1,270 | $73.02 | $93K | 130,982 |
| 2025-02-28 | Cowan Elvia SVP, FINANCE | Shares withheld for taxes | −242 | $73.02 | $18K | 24,431 |
| 2025-02-28 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Shares withheld for taxes | −470 | $73.02 | $34K | 42,236 |
| 2025-02-28 | Wassil Jim CHIEF OPERATING OFFICER | Grant or award 10b5-1 | +5,649 | $73.02 | $412K | 159,070 |
| 2025-02-28 | Wassil Jim CHIEF OPERATING OFFICER | Shares withheld for taxes 10b5-1 | −2,869 | $73.02 | $209K | 156,201 |
| 2025-02-28 | Wassil Jim CHIEF OPERATING OFFICER | Shares withheld for taxes 10b5-1 | −1,270 | $73.02 | $93K | 154,931 |
| 2025-02-28 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −2,013 | $73.02 | $147K | 506,226 |
| 2025-02-27 | GUGGENHIME ANDREW PRESIDENT AND CFO | Grant or award | +22,761 | 132,252 | ||
| 2025-02-27 | GUGGENHIME ANDREW PRESIDENT AND CFO | Grant or award · Stock Option (right to buy) | +75,991 | 75,991 | ||
| 2025-02-27 | Cowan Elvia SVP, FINANCE | Grant or award | +5,379 | 24,673 | ||
| 2025-02-27 | Cowan Elvia SVP, FINANCE | Grant or award · Stock Option (right to buy) | +17,961 | 17,961 | ||
| 2025-02-27 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Grant or award | +14,484 | 42,706 | ||
| 2025-02-27 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Grant or award · Stock Option (right to buy) | +48,357 | 48,357 | ||
| 2025-02-27 | Wassil Jim CHIEF OPERATING OFFICER | Grant or award 10b5-1 | +21,726 | 153,421 | ||
| 2025-02-27 | Wassil Jim CHIEF OPERATING OFFICER | Grant or award · Stock Option (right to buy) 10b5-1 | +72,536 | 72,536 |
Page 12 of 16 · 319 trades